483 Merck Sharp & Dohme Oct 2013

483 Merck Sharp & Dohme Oct 2013

Peter Lenahan FDA$119.00 - Available Now

FDA investigators audited the Merck Sharp & Dohme - Rahway, NJ, United States facility and issued inspectional observations (via FDA 483) on 16 Oct 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Oct 2013
  • Location: Rahway, United States
  • FEI: 2211017
Add To Cart